Other
ABL90 FLEX PLUS analyser running SW3.5 MR2.
ABL90 FLEX PLUS analyser running SW3.5 MR2. is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completed
25010 - ABL90 FLEX PLUS - Precision Capillary Adult - Clinical Study Protocol
NCT07307352
completed
ABL90 FLEX PLUS Clinical Precision Study for ctBil and FHbF Parameters in Neonatal Whole Blood
NCT05803694
completed
ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in Adult Whole Blood
NCT05804487
Clinical Trials (3)
Showing 3 of 3 trials
NCT07307352
25010 - ABL90 FLEX PLUS - Precision Capillary Adult - Clinical Study Protocol
NCT05803694
ABL90 FLEX PLUS Clinical Precision Study for ctBil and FHbF Parameters in Neonatal Whole Blood
NCT05804487
ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in Adult Whole Blood
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3